[Clinical Cancer Research] Scientists identified SPEN inactivation as a driver of androgen receptor pathway inhibitor resistance. SPEN inactivation results in upregulation of cell cycle proliferation and basal/stem cell activity as well as increased translation of pro-oncogenic genes.